Cargando…

Resolving the Pathogenesis of Anaplastic Wilms Tumors through Spatial Mapping of Cancer Cell Evolution

PURPOSE: While patients with intermediate-risk (IR) Wilms tumors now have an overall survival (OS) rate of almost 90%, those affected by high-stage tumors with diffuse anaplasia have an OS of only around 50%. We here identify key events in the pathogenesis of diffuse anaplasia by mapping cancer cell...

Descripción completa

Detalles Bibliográficos
Autores principales: Rastegar, Bahar, Andersson, Natalie, Petersson, Alexandra, Karlsson, Jenny, Chattopadhyay, Subhayan, Valind, Anders, Jansson, Caroline, Durand, Geoffroy, Romerius, Patrik, Jirström, Karin, Holmquist Mengelbier, Linda, Gisselsson, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for Cancer Research 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10345961/
https://www.ncbi.nlm.nih.gov/pubmed/37140929
http://dx.doi.org/10.1158/1078-0432.CCR-23-0311
_version_ 1785073208098029568
author Rastegar, Bahar
Andersson, Natalie
Petersson, Alexandra
Karlsson, Jenny
Chattopadhyay, Subhayan
Valind, Anders
Jansson, Caroline
Durand, Geoffroy
Romerius, Patrik
Jirström, Karin
Holmquist Mengelbier, Linda
Gisselsson, David
author_facet Rastegar, Bahar
Andersson, Natalie
Petersson, Alexandra
Karlsson, Jenny
Chattopadhyay, Subhayan
Valind, Anders
Jansson, Caroline
Durand, Geoffroy
Romerius, Patrik
Jirström, Karin
Holmquist Mengelbier, Linda
Gisselsson, David
author_sort Rastegar, Bahar
collection PubMed
description PURPOSE: While patients with intermediate-risk (IR) Wilms tumors now have an overall survival (OS) rate of almost 90%, those affected by high-stage tumors with diffuse anaplasia have an OS of only around 50%. We here identify key events in the pathogenesis of diffuse anaplasia by mapping cancer cell evolution over anatomic space in Wilms tumors. EXPERIMENTAL DESIGN: We spatially mapped subclonal landscapes in a retrospective cohort of 20 Wilms tumors using high-resolution copy-number profiling and TP53 mutation analysis followed by clonal deconvolution and phylogenetic reconstruction. Tumor whole-mount sections (WMS) were utilized to characterize the distribution of subclones across anatomically distinct tumor compartments. RESULTS: Compared with non-diffuse anaplasia Wilms tumors, tumors with diffuse anaplasia showed a significantly higher number of genetically distinct tumor cell subpopulations and more complex phylogenetic trees, including high levels of phylogenetic species richness, divergence, and irregularity. All regions with classical anaplasia showed TP53 alterations. TP53 mutations were frequently followed by saltatory evolution and parallel loss of the remaining wild-type (WT) allele in different regions. Morphologic features of anaplasia increased with copy-number aberration (CNA) burden and regressive features. Compartments demarcated by fibrous septae or necrosis/regression were frequently (73%) associated with the emergence of new clonal CNAs, although clonal sweeps were rare within these compartments. CONCLUSIONS: Wilms tumors with diffuse anaplasia display significantly more complex phylogenies compared with non-diffuse anaplasia Wilms tumors, including features of saltatory and parallel evolution. The subclonal landscape of individual tumors was constrained by anatomic compartments, which should be considered when sampling tissue for precision diagnostics.
format Online
Article
Text
id pubmed-10345961
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher American Association for Cancer Research
record_format MEDLINE/PubMed
spelling pubmed-103459612023-07-15 Resolving the Pathogenesis of Anaplastic Wilms Tumors through Spatial Mapping of Cancer Cell Evolution Rastegar, Bahar Andersson, Natalie Petersson, Alexandra Karlsson, Jenny Chattopadhyay, Subhayan Valind, Anders Jansson, Caroline Durand, Geoffroy Romerius, Patrik Jirström, Karin Holmquist Mengelbier, Linda Gisselsson, David Clin Cancer Res Translational Cancer Mechanisms and Therapy PURPOSE: While patients with intermediate-risk (IR) Wilms tumors now have an overall survival (OS) rate of almost 90%, those affected by high-stage tumors with diffuse anaplasia have an OS of only around 50%. We here identify key events in the pathogenesis of diffuse anaplasia by mapping cancer cell evolution over anatomic space in Wilms tumors. EXPERIMENTAL DESIGN: We spatially mapped subclonal landscapes in a retrospective cohort of 20 Wilms tumors using high-resolution copy-number profiling and TP53 mutation analysis followed by clonal deconvolution and phylogenetic reconstruction. Tumor whole-mount sections (WMS) were utilized to characterize the distribution of subclones across anatomically distinct tumor compartments. RESULTS: Compared with non-diffuse anaplasia Wilms tumors, tumors with diffuse anaplasia showed a significantly higher number of genetically distinct tumor cell subpopulations and more complex phylogenetic trees, including high levels of phylogenetic species richness, divergence, and irregularity. All regions with classical anaplasia showed TP53 alterations. TP53 mutations were frequently followed by saltatory evolution and parallel loss of the remaining wild-type (WT) allele in different regions. Morphologic features of anaplasia increased with copy-number aberration (CNA) burden and regressive features. Compartments demarcated by fibrous septae or necrosis/regression were frequently (73%) associated with the emergence of new clonal CNAs, although clonal sweeps were rare within these compartments. CONCLUSIONS: Wilms tumors with diffuse anaplasia display significantly more complex phylogenies compared with non-diffuse anaplasia Wilms tumors, including features of saltatory and parallel evolution. The subclonal landscape of individual tumors was constrained by anatomic compartments, which should be considered when sampling tissue for precision diagnostics. American Association for Cancer Research 2023-07-14 2023-05-04 /pmc/articles/PMC10345961/ /pubmed/37140929 http://dx.doi.org/10.1158/1078-0432.CCR-23-0311 Text en ©2023 The Authors; Published by the American Association for Cancer Research https://creativecommons.org/licenses/by-nc-nd/4.0/This open access article is distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) license.
spellingShingle Translational Cancer Mechanisms and Therapy
Rastegar, Bahar
Andersson, Natalie
Petersson, Alexandra
Karlsson, Jenny
Chattopadhyay, Subhayan
Valind, Anders
Jansson, Caroline
Durand, Geoffroy
Romerius, Patrik
Jirström, Karin
Holmquist Mengelbier, Linda
Gisselsson, David
Resolving the Pathogenesis of Anaplastic Wilms Tumors through Spatial Mapping of Cancer Cell Evolution
title Resolving the Pathogenesis of Anaplastic Wilms Tumors through Spatial Mapping of Cancer Cell Evolution
title_full Resolving the Pathogenesis of Anaplastic Wilms Tumors through Spatial Mapping of Cancer Cell Evolution
title_fullStr Resolving the Pathogenesis of Anaplastic Wilms Tumors through Spatial Mapping of Cancer Cell Evolution
title_full_unstemmed Resolving the Pathogenesis of Anaplastic Wilms Tumors through Spatial Mapping of Cancer Cell Evolution
title_short Resolving the Pathogenesis of Anaplastic Wilms Tumors through Spatial Mapping of Cancer Cell Evolution
title_sort resolving the pathogenesis of anaplastic wilms tumors through spatial mapping of cancer cell evolution
topic Translational Cancer Mechanisms and Therapy
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10345961/
https://www.ncbi.nlm.nih.gov/pubmed/37140929
http://dx.doi.org/10.1158/1078-0432.CCR-23-0311
work_keys_str_mv AT rastegarbahar resolvingthepathogenesisofanaplasticwilmstumorsthroughspatialmappingofcancercellevolution
AT anderssonnatalie resolvingthepathogenesisofanaplasticwilmstumorsthroughspatialmappingofcancercellevolution
AT peterssonalexandra resolvingthepathogenesisofanaplasticwilmstumorsthroughspatialmappingofcancercellevolution
AT karlssonjenny resolvingthepathogenesisofanaplasticwilmstumorsthroughspatialmappingofcancercellevolution
AT chattopadhyaysubhayan resolvingthepathogenesisofanaplasticwilmstumorsthroughspatialmappingofcancercellevolution
AT valindanders resolvingthepathogenesisofanaplasticwilmstumorsthroughspatialmappingofcancercellevolution
AT janssoncaroline resolvingthepathogenesisofanaplasticwilmstumorsthroughspatialmappingofcancercellevolution
AT durandgeoffroy resolvingthepathogenesisofanaplasticwilmstumorsthroughspatialmappingofcancercellevolution
AT romeriuspatrik resolvingthepathogenesisofanaplasticwilmstumorsthroughspatialmappingofcancercellevolution
AT jirstromkarin resolvingthepathogenesisofanaplasticwilmstumorsthroughspatialmappingofcancercellevolution
AT holmquistmengelbierlinda resolvingthepathogenesisofanaplasticwilmstumorsthroughspatialmappingofcancercellevolution
AT gisselssondavid resolvingthepathogenesisofanaplasticwilmstumorsthroughspatialmappingofcancercellevolution